Skip to content
20-F

Annual Report (Foreign)

Burning Rock Biotech Limited BNR

0001193125-25-101753

← back to feed
Filed
Apr 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex FY 2024 · Dec 31, 2024 $742K
Capex FY 2024 · Dec 31, 2022 ¥62.03M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$12.64M
Operating Cash Flow FY 2024 · Dec 31, 2022 −¥456.81M
Cash And Equivalents FY 2024 · Dec 31, 2024 $71.22M
Cash And Equivalents FY 2024 · Dec 31, 2022 ¥905.45M
Stockholders Equity FY 2024 · Dec 31, 2024 $79.57M
Stockholders Equity FY 2024 · Dec 31, 2021 ¥1.85B
Current Liabilities FY 2024 · Dec 31, 2024 $36.48M
Current Liabilities FY 2024 · Dec 31, 2023 ¥263.36M
Total Liabilities FY 2024 · Dec 31, 2024 $41.71M
Total Liabilities FY 2024 · Dec 31, 2023 ¥271.59M
Current Assets FY 2024 · Dec 31, 2024 $106.4M
Current Assets FY 2024 · Dec 31, 2023 ¥884.1M
Total Assets FY 2024 · Dec 31, 2024 $121.29M
Total Assets FY 2024 · Dec 31, 2023 ¥1.04B
Sga Expense FY 2024 · Dec 31, 2024 $35.84M
Sga Expense FY 2024 · Dec 31, 2022 ¥568.28M
Rd Expense FY 2024 · Dec 31, 2024 $31.82M
Rd Expense FY 2024 · Dec 31, 2022 ¥421.87M
Net Income FY 2024 · Dec 31, 2024 −$47.49M
Net Income FY 2024 · Dec 31, 2022 −¥971.23M
Operating Income FY 2024 · Dec 31, 2024 −$48.99M
Operating Income FY 2024 · Dec 31, 2022 −¥980.41M
Gross Profit FY 2024 · Dec 31, 2024 $49.65M
Gross Profit FY 2024 · Dec 31, 2022 ¥380.04M
Cost Of Revenue FY 2024 · Dec 31, 2024 $21.02M
Cost Of Revenue FY 2024 · Dec 31, 2022 ¥183.2M
Revenue FY 2024 · Dec 31, 2024 $70.67M
Revenue FY 2024 · Dec 31, 2022 ¥563.24M